AI Pathway Optimization for Synthetic Biology Bottlenecks
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Synthetic biology processes are capital intensive, painstaking, and uncertain, requiring lab-driven approaches that hinder rapid innovation and scalability.
Innovation Solution
An AI-guided synthetic biology platform that integrates and normalizes diverse biologic data, applies machine learning models, and performs multi-objective optimizations to enhance data quality and predict biologic system designs, addressing batch-specific systemic variations and technical factors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If lab-driven approaches are used for synthetic biology development, then experimental control and data quality are maintained, but development cost and time increase significantly
Solution Approach 1:
The patent creates virtual copies of biological experiments through AI simulations and digital twins, allowing researchers to test multiple hypotheses computationally before performing physical experiments. This reduces the number of costly lab iterations while maintaining data quality through validated computational models.
Solution Approach 2:
The platform performs preliminary computational screening, pathway analysis, and experiment design before actual lab work begins. By pre-optimizing experimental parameters and predicting outcomes through AI models, the system reduces unnecessary laboratory trials and accelerates the development cycle.
2Adaptability or versatility
If diverse data sources are integrated without standardization, then data comprehensiveness increases, but data quality and reliability decrease due to batch effects and format variations
Solution Approach 1:
The patent applies parameter transformation techniques to convert diverse data formats into a unified standardized schema. By systematically transforming data parameters across different sources while preserving biological meaning, the platform achieves both comprehensive data integration and consistent data quality.
Solution Approach 2:
The platform introduces an intermediary data normalization layer that acts as a mediator between diverse data sources and analytical models. This intermediary standardizes data formats, corrects batch effects, and harmonizes variations without losing the adaptability to handle multiple data types.
3Reliability
If traditional sequential development methods are used, then process control is maintained, but development time and resource consumption increase
Solution Approach 1:
The patent transforms static sequential development into a dynamic parallel processing system where multiple experiments, simulations, and analyses occur simultaneously. The platform dynamically coordinates these parallel activities while maintaining process control through real-time monitoring and adaptive resource allocation.
Solution Approach 2:
The system eliminates idle time between development stages by implementing continuous workflows where data from one process immediately feeds into the next. Automated data pipelines and real-time analysis ensure that useful actions continue uninterrupted, reducing overall development cycle time while maintaining control.
Data Source
AI summary
Platforms, systems, and methods for pathway optimization for process bottlenecks in synthetic biology development. According to one aspect, there is provided a method of optimizing a biologic synthesis process, comprising: identifying at least one bottleneck in the biologic synthesis process; evaluating a set of variants of the biologic synthesis process; and selecting an adjusted biologic synthesis process, wherein the adjusted biologic synthesis process includes at least one variant of the set of variants that reduces the at least one bottleneck of the biologic synthesis process.